Brief: Extrawell Pharmaceutical Holdings says FY profit attributable HK$20.8 million
29/06/2017 15:54
June 29 (Reuters) - Extrawell Pharmaceutical Holdings Ltd
0858.HK :
* Directors do not recommend payment of dividend for year
ended 31 March 2017
* FY profit attributable hk$20.8 million versus hk$32.8
million
* FY revenue hk$107.9 million versus hk$142.2 million
Source text for Eikon: ID:nHKS8BPLbl
Further company coverage: 0858.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million